Identification of promoter region of ghrelin gene in human medullary thyroid carcinoma cell line

被引:23
作者
Nakai, N
Kaneko, M
Nakao, N
Fujikawa, T
Nakashima, K
Ogata, M
Tanaka, M
机构
[1] Mie Univ, Fac Med, Dept Biochem, Tsu, Mie 5148507, Japan
[2] Nippon Vet & Anim Sci Univ, Fac Appl Life Sci, Dept Anim Sci, Tokyo 1808602, Japan
关键词
ghrelin; transcription initiation site; promoter; gene expression; thyroid carcinoma cells; human;
D O I
10.1016/j.lfs.2004.04.028
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Ghrelin, an endogenous ligand for growth hormone (GH) secretagogue receptor, stimulates GH secretion. The ghrelin gene is expressed most abundantly in stomach. The mRNA is also detected in other tissues and cell lines. However, the mechanism of the transcriptional regulation of the ghrelin gene has not yet been clarified. In the present study, we have investigated the regulatory region of the ghrelin gene expression in the human medullary thyroid carcinoma cell line (TT cells). PCR analysis of the 5'-region for human ghrelin gene revealed the presence of the first exon corresponding to the short non-coding first exon of the mouse ghrelin gene. The first exon is located at the 502 by upstream from the 5'-end of the formerly reported human ghrelin gene. RT PCR analysis showed the expression of the first exon in the stomach and TT cells. The expression of the first exon in the human stomach was confirmed by 5'-RACE method. Significant level of promoter activity was observed in the 1225-1107 by up-stream region of the translation initiation site by luciferase assay. Specific protein binding to the promoter region of -1129 to -1100 was detected by electrophoretic mobility shift assay with nuclear extract from TT cells. These results suggest that the ghrelin gene expression in TT cells might be regulated by the upstream region of the first exon. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:2193 / 2201
页数:9
相关论文
共 26 条
[11]  
King MK, 2001, CIRCULATION, V103, P308
[12]   Ghrelin is a growth-hormone-releasing acylated peptide from stomach [J].
Kojima, M ;
Hosoda, H ;
Date, Y ;
Nakazato, M ;
Matsuo, H ;
Kangawa, K .
NATURE, 1999, 402 (6762) :656-660
[13]   The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors [J].
Korbonits, M ;
Bustin, SA ;
Kojima, M ;
Jordan, S ;
Adams, EF ;
Lowe, DG ;
Kangawa, K ;
Grossman, AB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :881-887
[14]   Kidney produces a novel acylated peptide, ghrelin [J].
Mori, K ;
Yoshimoto, A ;
Takaya, K ;
Hosoda, K ;
Ariyasu, H ;
Yahata, K ;
Mukoyama, M ;
Sugawara, A ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Nakao, K .
FEBS LETTERS, 2000, 486 (03) :213-216
[15]   Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure [J].
Nagaya, N ;
Uematsu, M ;
Kojima, M ;
Ikeda, Y ;
Yoshihara, F ;
Shimizu, W ;
Hosoda, H ;
Hirota, Y ;
Ishida, H ;
Mori, H ;
Kangawa, K .
CIRCULATION, 2001, 104 (12) :1430-1435
[16]   Hemodynamic and hormonal effects of human ghrelin in healthy volunteers [J].
Nagaya, N ;
Kojima, M ;
Uematsu, M ;
Yamagishi, M ;
Hosoda, H ;
Oya, H ;
Hayashi, Y ;
Kangawa, K .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (05) :R1483-R1487
[17]   Ghrelin immunoreactivity in human plasma is suppressed by somatostatin [J].
Norrelund, H ;
Hansen, TK ;
Orskov, H ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Weeke, J ;
Moller, N ;
Christiansen, JS ;
Jorgensen, JOL .
CLINICAL ENDOCRINOLOGY, 2002, 57 (04) :539-546
[18]   Somatostatin suppresses ghrelin secretion from the rat stomach [J].
Shimada, M ;
Date, Y ;
Mondal, MS ;
Toshinai, K ;
Shimbara, T ;
Fukunaga, K ;
Murakami, N ;
Miyazato, M ;
Kangawa, K ;
Yoshimatsu, H ;
Matsuo, H ;
Nakazato, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (03) :520-525
[19]   Organization of the mouse ghrelin gene and promoter: Occurrence of a short noncoding first exon [J].
Tanaka, M ;
Hayashida, Y ;
Iguchi, T ;
Nakao, N ;
Nakai, N ;
Nakashima, K .
ENDOCRINOLOGY, 2001, 142 (08) :3697-3700
[20]   Somatostatin acts by inhibiting the cyclic 3',5'-adenosine monophosphate (cAMP)/protein kinase A pathway, cAMP response element-binding protein (CREB) phosphorylation, and CREB transcription potency [J].
Tentler, JJ ;
Hadcock, JR ;
GutierrezHartmann, A .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (07) :859-866